Navigation Links
Thomson Reuters Releases Micromedex 2.0
Date:12/7/2009

ANN ARBOR, Mich., Dec. 7 /PRNewswire/ -- Thomson Reuters today announced the release of Micromedex 2.0, the newest version of its market-leading clinical information system.

Pharmacists, nurses, and physicians in more than 3,500 hospitals in 83 countries use Micromedex, which provides evidence-based information on drugs, disease management, toxicology, neonatal dosing, alternative medicines, and patient education.

The new version gives clinicians the same content that has made Micromedex the market leader over the last 30 years -- along with significant user interface and search modifications that improve the way they access and use the information. New features include an interface based on clinician workflow patterns, enhanced search capabilities, special tabs for high-usage tools, and compatibility with iPhone®, iPod® Touch, BlackBerry® smartphones, and other mobile devices.

Micromedex 2.0 will be available to all current customers at no additional charge beginning January 21, 2010.

Built using an iterative design process that involved more than 60 clinician-user interviews, Micromedex 2.0 offers several improvements over previous versions and competing solutions:

  • Enhanced search functions including multi-term search, predictive text, synonyms and suggestions for alternate spellings, and a single search box on every page.
  • A 360-degree view of results providing a complete picture of all available information about a drug or condition on a single screen -- including drug summaries, images, consults, comparative efficacy, labeled and off-label indications, treatment options, and more.
  • Separate tabs for high-usage tools - including a calculators tab with 22 separate dosing, laboratory value, antidote, and measurement calculators, and tabs for Trissel's (TM)2 IV compatibility, drug identification with images, and comprehensive drug interaction checking.
  • Support for the Safari and Opera Mini browsers, which provides for access via iPhone, iPod Touch, BlackBerry, and hundreds of other mobile devices.
  • Clean interface design that makes it easy for clinicians to interact with evidence-based content.

"Micromedex has always had great evidence-based clinical content," said Dennis Killian, Pharm.D., Ph.D., director of pharmacy at Peninsula Regional Medical Center in Salisbury, Maryland. "With 2.0, they have rebuilt the search and user interface to fit the way clinical people work. Multi-term searching gets you to the answer you need more quickly than before, and the 360-degree dashboard displays all the different types of information available for a specific drug."

"Micromedex 2.0 represents the intersection of integrated evidence-based clinical content and user-centered design," said Thomas Hegelund, executive vice president for the Healthcare & Science business of Thomson Reuters. "By using Micromedex 2.0, hospital clinicians get the right answer, quickly, along with the certainty that they are acting on the best evidence available."

Customers can call 1-877-843-6796 and say "Micromedex" to schedule an upgrade to Micromedex 2.0.

To learn more about the new solution, visit the Thomson Reuters booth (#2207) at the American Society of Health System Pharmacists (ASHP) Midyear Clinical Meeting this week, or visit www.micromedex.com/2.

Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people and operates in over 100 countries. Thomson Reuters shares are listed on the Toronto Stock Exchange (TSX: TRI) and New York Stock Exchange ( TRI). For more information, go to www.thomsonreuters.com.

SOURCE Thomson Reuters


'/>"/>
SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Thomson Reuters Survey: Most Americans Support Public Option in Healthcare Reform Legislation but Are Skeptical Healthcare Will Improve in 2010
2. Hospital Financials Have Recovered to Pre-Recession Levels, According to Thomson Reuters Study
3. Waste in the U.S. Healthcare System Pegged at $700 Billion in Report From Thomson Reuters
4. Halifax Regional Medical Center Selects Micromedex Solutions from Thomson Reuters for Clinical Decision Support
5. Thomson Reuters Survey: Americans Skeptical That Healthcare Reform Will Improve Quality or Affordability
6. Thomson Reuters Launches Thomson Pharma Partnering Forecast
7. Rush-Copley Medical Center Uses Thomson Reuters Order Sets Solution to Improve Joint Commission S3 Scores
8. Thomson Reuters Study Finds Healthcare Consumer Confidence Improved 12 Percent Since March
9. Thomson Reuters Survey: Americans Skeptical that Healthcare Reform Will Improve Quality or Affordability
10. BryanLGH Health System Selects Clinical Xpert From Thomson Reuters to Improve Clinical Quality
11. Thomson Reuters Study Finds Impact of Recession Easing on U.S. Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work ... as “patient engagement.” The patient is doing more than filling out a survey; in ... “There is an increasing emphasis in health care and research on the importance of ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and ... Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD ... that can be easily incorporated into liquid products, while reducing costs to end users. ...
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- AllianceRx Walgreens Prime, the combined central specialty pharmacy and ... manager Prime Therapeutics LLC (Prime), today officially began the ... of new signage at its headquarters in ... few other company-owned facilities across the country. This also ... whom will begin to see the AllianceRx Walgreens Prime ...
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans ... advance the use of wearable and home sensors for ... disorders. Early Signal Foundation, a nonprofit organization focused on ... will provide an affordable analytical system to record and ... ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
Breaking Medicine Technology: